Target intelligence / Profile preview

DNA guanine 2-amino group (N2-guanine)

Target
N2-guanine
Molecular classification
Nucleic acid, Genomic DNA
01

Overview

The DNA guanine 2-amino group, also known as the N2 position, is a nucleophilic site located within the minor groove of the DNA double helix (Tomasz, 1995). While guanine is a fundamental building block of genetic material, its 2-amino group is specifically targeted by a class of anti-tumor agents known as minor groove alkylators, including the marine-derived compound trabectedin and its synthetic derivative lurbinectedin (Markham, 2020). Unlike many DNA-damaging agents that target the major groove or the N7 position of guanine, drugs targeting the N2-amino group form stable covalent adducts that distort the DNA architecture by bending it toward the major groove (D'Incalci & Galmarini, 2010). This structural distortion interferes with the recruitment of transcription factors and the processing of DNA by various enzymes. Crucially, the presence of these adducts triggers a unique 'poisoning' effect on the nucleotide excision repair (NER) system; instead of repairing the damage, the NER machinery is recruited in a way that generates lethal double-strand breaks, leading to apoptosis in rapidly dividing cancer cells (Marco & Gago, 2005). This mechanism makes the N2-guanine position a highly effective target for treating transcriptionally active malignancies such as soft tissue sarcomas and small cell lung cancer.

Other names
Guanine N2 position2-amino group of guanineN2-deoxyguanosineN2-dGDNA minor groove guanine amino group
02

Mechanism of action

Covalent alkylation of the N2 position of guanine within the DNA minor groove (D'Incalci & Galmarini, 2010). This binding causes the DNA helix to bend toward the major groove, which disrupts the binding of transcription factors and interferes with the activity of RNA polymerase II. Furthermore, these adducts trap the nucleotide excision repair (NER) machinery, specifically the XPG and ERCC1 proteins, leading to the formation of lethal DNA double-strand breaks (Marco & Gago, 2005).

03

Biological functions

Genetic information storageDNA replicationTranscriptionHydrogen bondingStructural integrity of the DNA minor groove
04

Disease associations

CancerSoft tissue sarcomaOvarian cancerSmall cell lung cancer
05

Safety considerations

MyelosuppressionHepatotoxicitySecondary malignanciesNeutropeniaThrombocytopenia
06

Interacting drugs

Trabectedin

4 more in the full profile.

07

Biomarkers

ERCC1 expression levelsXPG (ERCC5) statusDNA adduct formationHomologous recombination deficiency (HRD) status

Beyond the preview

Go deeper on DNA guanine 2-amino group (N2-guanine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA guanine 2-amino group (N2-guanine).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call